Table 1.
Baseline characteristics.
| n = 153 | |
|---|---|
| Age, years | 46.5 ± 12.7 |
| Female, n (%) | 101 (66%) |
| Body mass index, kg/m2 | 25.8 ± 4.4 |
| Symptoms on admission | |
| Fever, n (%) | 75 (49) |
| Sore throat, n (%) | 64 (42) |
| Fatigue, n (%) | 113 (74) |
| Cough, n (%) | 100 (65) |
| Hyposmia, dysosmia, or anosmia, n (%) | 26 (17) |
| Headache, n (%) | 10 (7) |
| Dyspnea, n (%) | 60 (39) |
| Myalgia, n (%) | 59 (39) |
| Diarrhea, n (%) | 5 (3) |
| Medications | |
| Favipiravir, n (%) | 120 (78) |
| Chloroquine/hydroxychloroquine, n (%) | 117 (77) |
| Azithromycin, n (%) | 49 (32) |
| Anti-coagulant use, n (%) | 58 (38) |
| Steroid, n (%) | 0 (0) |
| High dose of steroid, n (%) | 0 (0) |
| Tocilizumab, n (%) | 0 (0) |
| Follow-up time, days | 31.6 ± 5.0 |
| In-hospital follow-up, n (%) | 8 (5) |
| Hospital stay, days | 6.1 ± 1.0 |